DMK Pharma Says Contaminated Injectors Led To Ch. 11 Filing
Drugmaker DMK Pharmaceuticals Corp. has filed an adversary complaint in Delaware bankruptcy court, saying its epinephrine-injector supplier failed to maintain contaminant-free manufacturing facilities sold to the debtor, which caused one of...To view the full article, register now.
Already a subscriber? Click here to view full article